+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Xenotransplantation Market Report 2025 - Product Thumbnail Image

Xenotransplantation Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Anticoagulants Market Report 2025 - Product Thumbnail Image

Anticoagulants Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Blood Bank Market Report 2025 - Product Thumbnail Image

Blood Bank Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Blood Preparation Market Report 2025 - Product Thumbnail Image

Blood Preparation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Myocardial Infarction - Pipeline Insight, 2025 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Dermatomyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Dermatomyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator